Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announce Nature ...
yourlifechoices.com.au3h
The COVID vaccine Aussies can’t get
With winter almost here, many Australians are heading to doctors and pharmacies for their annual flu vaccines. But although ...
Techno-Science on MSN4d
🧬 Encouraging results for this mRNA cancer vaccine
The University of Florida recently developed a cancer vaccine using mRNA technology. This innovative vaccine targets ...
AlphaGalileo19h
Long-Term Protection from SARS-CoV-2 Variants in Mice by a Phase II Clinically Evaluated Original mRNA Vaccine Booster
This article discussed the development of an mRNA vaccine (LVRNA009) that encoded the S protein of the Wuhan-Hu-1 strain and evaluated the long-term protection potential against SARS-CoV-2 variants.
The Bangkok Post on MSN3d
mRNA vaccine due for first clinical trial
Mahidol University has inched closer to starting the world's first clinical trial of an mRNA vaccine against malaria.
Revolutionary mRNA Cancer Vaccine Shows Immense Promise in First-Ever Human Clinical Trial
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine created at the University of Florida ...
Seeking Alpha on MSN2d
Moderna vaccine patent upheld by European Patent Office: report
The European Patent Office has reportedly upheld the validity of Moderna’s (NASDAQ:MRNA) 949 patent for its COVID-19 ...
San Diego biotech news: Local maker of mRNA used in COVID-19 vaccine opens new facility
The local manufacturing facility will support the growing momentum behind mRNA-based medicines and vaccines beyond COVID-19.
Moderna Japan aiming for combined COVID-flu mRNA vaccine clinical trials this winter
Pharmaceutical firm Moderna Japan is aiming to start clinical trials this winter for a combined vaccine using messenger RNA ...